Your cart is empty.
Ambry Genetics in California is taking advantage of the increased throughput, reliability and reproducibility of laboratory automation, using Freedom EVO® workstations to streamline its genetic testing workflows for cancers, cystic fibrosis and numerous inherited diseases.
The University of North Carolina (UNC) has automated its major sample preparation protocols for next generation sequencing on a Freedom EVO® workstation, enabling more efficient processing.
Researchers at ISPRA have been trialing the TouchTools PCR Wizard for the Freedom EVO® PCR workstation to simplify complex genetic testing workflows. This software enables rapid selection and walkaway set-up of pre-PCR protocols suitable for a wide range of downstream analytical techniques.
GUK-based Oxford BioDynamics has automated its proprietary biomarker discovery platform, EpiSwitch™, on a Freedom EVO® 150, helping to establish a NGS, CGH-array and PCR-based pipeline for the discovery of novel biomarkers, as well as a PCR protocol for biomarker-based diagnostic testing.
The Albert Einstein College of Medicine is using a Freedom EVO® platform to automate sample handling and library preparation for next generation sequencing.
Carrier screening based on next generation DNA sequencing has been completely automated at Good Start Genetics® Inc., with proprietary chemistry and customized protocols on six Freedom EVO® platforms giving significantly better turnaround times and increased reliability and reproducibility.
The Dittmer Lab at the University of North Carolina is investigating the biology of viral cancers using a Freedom EVO® 150 with an integrated LightCycler® 480 Real-Time PCR System. This versatile set-up provides automated qPCR-based analysis for viral gene and microRNA expression profiling, as well as viral load testing of clinical trial samples.
Russia’s Central Tuberculosis Research Institute is using a Freedom EVO® orkstation to help in the fight against tuberculosis. The platform provides fast and secure sample preparation, allowing molecular diagnosis of M. tuberculosis infection in just a few hours.
The recently launched Gas Control Module for the Infi nite® 200 PRO is off ering researchers at the University of Salzburg a new approach to the investigation of cellular processes, allowing incubation of cells within the reader for the fi rst time.
The Centro Nacional de Investigaciones Cardiovasculares has developed Automatic Genomics, a software application that enables automation of medium throughput qPCR assays on the Freedom EVO® liquid handling platform.
St Mary’s Hospital, Manchester, is using a fully automated DNA extraction system based on a Freedom EVOR workstation.This system provides walkaway extraction of DNA from blood samples by combining a Freedom EVO 150 liquid handling platform with chemagen’s proven nucleic isolation technology.
Reliable high throughput genotyping on the Tecan Freedom EVO® 200 platform has helped research in parenthood analysis and population genetics of the three-spined stickleback at the Max Planck Institute for Evolutionary Biology, Plön, Germany.
Tecan systems are providing an integrated solution to researchers at Stanford Genome Technology Center for the study of yeast genomics.